CN102697868A - Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis - Google Patents

Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis Download PDF

Info

Publication number
CN102697868A
CN102697868A CN2012100004520A CN201210000452A CN102697868A CN 102697868 A CN102697868 A CN 102697868A CN 2012100004520 A CN2012100004520 A CN 2012100004520A CN 201210000452 A CN201210000452 A CN 201210000452A CN 102697868 A CN102697868 A CN 102697868A
Authority
CN
China
Prior art keywords
parts
radix
urticaria
lupus erythematosus
immunity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012100004520A
Other languages
Chinese (zh)
Inventor
陈玉堂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012100004520A priority Critical patent/CN102697868A/en
Publication of CN102697868A publication Critical patent/CN102697868A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis and called skin disease therapeutic drug No. one. The medicine comprises glossy ganoderma, ginseng, epimedium, astragalus, polygonum cuspidatum, cordyceps sinensis, kuh-seng and liquorice. The medicine is prepared by pure traditional Chinese medicine, has functions of regulating and improving human immunity, anti-bacterium and itching relieving effect, curing various skin diseases such as lupus erythematosus, urticaria and psoriasis, and has the advantages of fine therapeutic effect, low side effect, short treatment course, effectiveness and high cure rate.

Description

A kind of immunity of regulating is cured lupus erythematosus, urticaria, psoriatic medicine
[technical field]
The present invention relates to a kind of pharmaceutical formulation, relate in particular to a kind of a kind of immunity of regulating that can treat multiple disease simultaneously and cure lupus erythematosus, urticaria, psoriatic medicine.
[background technology]
In process is cured the disease in present clinical application, generally all be to be main with the single relatively medicine of function, can not satisfy the requirement of the multiple disease of treatment.And because existing medicine a multitude of names, general patient is difficult to select the medicine treatment according to self disease oneself.
In addition, it is Western medicine greatly that existing medicine has, and not only expensive makes general ordinary people be difficult to bear, and has toxic and side effects usually, and patient is long-term or take in a large number and can cause the human body viscera damage and develop immunity to drugs, thoroughly radical curing of disease.Some people also can produce the phenomenon of vomiting when taking Western medicine, thereby has increased patient's misery.
In this case, people turn to the traditional Chinese medical science to the hope of treatment.Yet, the medicine that still unmatchful multiple disease can be treated simultaneously in the traditional Chinese medical science at present.
Therefore, for avoiding the problems referred to above, necessaryly provide a kind of and can regulate body immunity, cure lupus erythematosus and psoriatic Chinese patent medicine, to overcome said defective of the prior art.
[summary of the invention]
For addressing the above problem, the object of the present invention is to provide a kind of therapeutic effect good, side effect is little, short treating period, and can treat a kind of of multiple disease simultaneously and can regulate body immunity, cure lupus erythematosus and psoriatic Chinese patent medicine.
Be to realize above-mentioned purpose, the technical scheme that the present invention takes is: a kind ofly can regulate body immunity, cure lupus erythematosus and psoriatic Chinese patent medicine, it comprises Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, Radix Sophorae Flavescentis and Radix Glycyrrhizae.
A kind of immunity of regulating of the present invention is cured lupus erythematosus, urticaria, and psoriatic medicine further is: said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, the proportioning of Radix Sophorae Flavescentis and Radix Glycyrrhizae is (parts by weight are represented): 10~14 parts of Ganodermas; 7~9 parts of Radix Ginsengs; 15~20 parts of Herba Epimedii; 9~11 parts of the Radixs Astragali; 10~12 parts of Rhizoma Polygoni Cuspidati; 6~8 parts of Cordycepses; 11~15 parts of Radix Sophorae Flavescentiss; 11~15 parts in Radix Glycyrrhizae.
A kind of immunity of regulating of the present invention is cured lupus erythematosus, urticaria, and psoriatic medicine further is: said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, the proportioning of Radix Sophorae Flavescentis and Radix Glycyrrhizae is (parts by weight are represented): 11 parts of Ganodermas; 8 parts of Radix Ginsengs; 17 parts of Herba Epimedii; 10 parts of the Radixs Astragali; 11 parts of Rhizoma Polygoni Cuspidati; 7 parts of Cordycepses; 12 parts of Radix Sophorae Flavescentiss; 12 parts in Radix Glycyrrhizae.
A kind of immunity of regulating of the present invention is cured lupus erythematosus, urticaria, psoriatic medicine can also for: said pharmaceutical formulation can be processed tablet, capsule, electuary, oral liquid or injection.
Compared with prior art, the present invention has following beneficial effect: a kind of immunity of regulating of the present invention is cured lupus erythematosus, urticaria, and psoriatic medicine is that pure Chinese medicine is processed, and it is good to have a therapeutic effect, and side effect is little, plurality of advantages such as short treating period; The effect of body immunity and anti-bacterial, anti-itching is regulated and improved to tool.Various dermatosiss such as treatment lupus erythematosus, psoriasis, eczema, urticaria.The high characteristics of instant effect cure rate are arranged.。
[specific embodiment]
Below in conjunction with embodiment the present invention is done further explanation.
Embodiment 1:
A kind of immunity of regulating of the present invention is cured lupus erythematosus, urticaria, and psoriatic medicine is made up of following Chinese medicine: Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, Radix Sophorae Flavescentis and Radix Glycyrrhizae.Wherein, said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, the proportioning of Radix Sophorae Flavescentis and Radix Glycyrrhizae is (parts by weight are represented): 10~14 parts of Ganodermas; 7~9 parts of Radix Ginsengs; 15~20 parts of Herba Epimedii; 9~11 parts of the Radixs Astragali; 10~12 parts of Rhizoma Polygoni Cuspidati; 6~8 parts of Cordycepses; 11~15 parts of Radix Sophorae Flavescentiss; 11~15 parts in Radix Glycyrrhizae.Said pharmaceutical formulation is processed tablet, capsule, and electuary, oral liquid or injection are to satisfy the many-sided demand of patient.
Embodiment 2:
A kind of immunity of regulating of the present invention is cured lupus erythematosus, urticaria, and psoriatic medicine is made up of following Chinese medicine: Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, Radix Sophorae Flavescentis and Radix Glycyrrhizae.Wherein, said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, the proportioning of Radix Sophorae Flavescentis and Radix Glycyrrhizae is (parts by weight are represented): 11 parts of Ganodermas; 8 parts of Radix Ginsengs; 17 parts of Herba Epimedii; 10 parts of the Radixs Astragali; 11 parts of Rhizoma Polygoni Cuspidati; 7 parts of Cordycepses; 12 parts of Radix Sophorae Flavescentiss; 12 parts in Radix Glycyrrhizae.Said pharmaceutical formulation is processed tablet, capsule, and electuary, oral liquid or injection are to satisfy the many-sided demand of patient.
A kind of immunity of regulating of the present invention is cured lupus erythematosus, urticaria, and psoriatic medicine is that pure Chinese medicine is processed, and it is good to have a therapeutic effect, and side effect is little, plurality of advantages such as short treating period; The effect of body immunity and anti-bacterial, anti-itching is regulated and improved to tool.Various dermatosiss such as treatment lupus erythematosus, psoriasis, eczema, urticaria.The high characteristics of instant effect cure rate are arranged.
The above specific embodiment is merely the preferred embodiment of this creation, not in order to limiting this creation, any modification of being made within all spirit and principles in this creation, is equal to replacement, improvement etc., all should be included within the protection domain of this creation.

Claims (4)

1. can regulate immunity healing lupus erythematosus for one kind, urticaria, psoriatic medicine is characterized in that: comprise Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, Radix Sophorae Flavescentis and Radix Glycyrrhizae.
2. a kind of immunity of regulating as claimed in claim 1 is cured lupus erythematosus, urticaria, and psoriatic medicine is characterized in that: said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Cordyceps, the proportioning of Radix Sophorae Flavescentis and Radix Glycyrrhizae is (parts by weight are represented):
10~14 parts of Ganodermas;
7~9 parts of Radix Ginsengs;
15~20 parts of Herba Epimedii;
9~11 parts of the Radixs Astragali;
10~12 parts of Rhizoma Polygoni Cuspidati;
6~8 parts of Cordycepses;
11~15 parts of Radix Sophorae Flavescentiss;
11~15 parts in Radix Glycyrrhizae.
3. a kind of immunity of regulating as claimed in claim 2 is cured lupus erythematosus, urticaria, and psoriatic medicine is characterized in that: said Ganoderma; Radix Ginseng, Herba Epimedii, the Radix Astragali; Rhizoma Polygoni Cuspidati, Cordyceps, the proportioning of Radix Sophorae Flavescentis and Radix Glycyrrhizae is (parts by weight are represented): 11 parts of Ganodermas; 8 parts of Radix Ginsengs; 17 parts of Herba Epimedii; 10 parts of the Radixs Astragali; 11 parts of Rhizoma Polygoni Cuspidati; 7 parts of Cordycepses; 12 parts of Radix Sophorae Flavescentiss; 12 parts in Radix Glycyrrhizae.
4. a kind of immunity of regulating as claimed in claim 3 is cured lupus erythematosus, urticaria, and psoriatic medicine is characterized in that: said pharmaceutical formulation can be processed tablet, capsule, electuary, oral liquid or injection.The effect of body immunity and anti-bacterial, anti-itching is regulated and improved to tool.Various dermatosiss such as treatment lupus erythematosus, psoriasis, eczema, urticaria.The high characteristics of instant effect cure rate are arranged.
CN2012100004520A 2012-01-04 2012-01-04 Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis Pending CN102697868A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012100004520A CN102697868A (en) 2012-01-04 2012-01-04 Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012100004520A CN102697868A (en) 2012-01-04 2012-01-04 Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis

Publications (1)

Publication Number Publication Date
CN102697868A true CN102697868A (en) 2012-10-03

Family

ID=46891115

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012100004520A Pending CN102697868A (en) 2012-01-04 2012-01-04 Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis

Country Status (1)

Country Link
CN (1) CN102697868A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013177944A1 (en) * 2012-05-29 2013-12-05 江中药业股份有限公司 Use of composition in preparing health care products or medicines for preventing and treating allergic diseases
CN105213925A (en) * 2015-11-10 2016-01-06 王庆阳 A kind ofly treat medicine of scalp psoriasis pustulosa and preparation method thereof
CN105748571A (en) * 2014-12-19 2016-07-13 烟台宝备生物技术有限公司 Drug or health food with immunity enhancing effect
CN107854576A (en) * 2017-11-27 2018-03-30 江苏辉腾环保科技有限公司 A kind of antipsoriatics thing component and preparation method thereof
CN110404012A (en) * 2019-08-22 2019-11-05 郑奎 A kind of Chinese materia medica preparation and preparation method thereof with bacteriostasis

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013177944A1 (en) * 2012-05-29 2013-12-05 江中药业股份有限公司 Use of composition in preparing health care products or medicines for preventing and treating allergic diseases
US10086030B2 (en) 2012-05-29 2018-10-02 Jiangzhong Pharmaceutical Co., Ltd. Use of composition in preparing health care products or medicines for preventing and treating allergic diseases
CN105748571A (en) * 2014-12-19 2016-07-13 烟台宝备生物技术有限公司 Drug or health food with immunity enhancing effect
CN105213925A (en) * 2015-11-10 2016-01-06 王庆阳 A kind ofly treat medicine of scalp psoriasis pustulosa and preparation method thereof
CN107854576A (en) * 2017-11-27 2018-03-30 江苏辉腾环保科技有限公司 A kind of antipsoriatics thing component and preparation method thereof
CN110404012A (en) * 2019-08-22 2019-11-05 郑奎 A kind of Chinese materia medica preparation and preparation method thereof with bacteriostasis

Similar Documents

Publication Publication Date Title
CN102697942A (en) Medicament capable of killing cancer cells and curing various tumors and cancers and leukemia
CN102247541A (en) Medicament for treating hepatorenal disease, diabete, asthma, rheumatism, and dermatoma
CN102697868A (en) Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis
CN102697898A (en) Medicament for regulating endocrine and curing dysmenorrheal, mammary gland hyperplasia and breast dysplasia
CN102343038A (en) Medicament for treating cerebrosis such as hemiplegic cerebral palsy, falling sickness, Parkinson, headache, insomnia and the like
CN102327493A (en) Medicine for treating tracheitis, rhinitis, pharyngitis, pneumonectasis, pulmonary heart diseases and asthmatic diseases
CN104306846A (en) Traditional Chinese medicine for treating attention deficit hyperactivity disorder
CN103372083A (en) Chinese medicinal composition for treating spontaneous perspiration
CN102670817A (en) Medicament for treating various blood diseases such as thrombocytopenia, purpura and leukaemia
CN102423359A (en) Drug for restoring renal functions and curing various nephrosis such as nephritis, uremia and the like
CN104398915A (en) Traditional Chinese medicinal composition for chronic eczema
CN101468189A (en) Chinese medicine for treating rhinitis
CN102327492A (en) Medicine for treating amyotrophia and myasthenia, myodystrophy and motor neuron injury
CN102343039A (en) Drug for treating skin diseases such as psoriasis, leucoderma, ichthyosis, eczema and the like
CN101239140A (en) Chinese medicine for treating psoriasis
CN102327491A (en) Medicine for treating venereal diseases, such as prostatosis, condyloma acuminatum, gonorrhea syphilis and aids
CN105311460A (en) Traditional Chinese medicine for treating vascular neuralgia headache
CN102343042A (en) Medicine for treating cardiovascular diseases of hypertension, cardiopathy and cerebral thrombus
CN102343040A (en) Drug for treating otitis media, deaf and tinnitus
CN102343037A (en) Drug with effects of bacterium resistance, disinfection, blood circulation promotion, blood stasis removal, immunity improvement, life prolonging and aging delay
CN103520289A (en) Chinese medicinal composition for treating constipation, preparation method and application thereof
CN102697869A (en) Medicine capable of regulating blood surger level, restoring pancreatic function and curing diabetes mellitus
CN102125653A (en) Anti-inflammatory antitussive medicine
CN105770548A (en) Externally-used traditional Chinese medicine for treating skin eczema
CN102430007A (en) Weight-losing Chinese patent medicine capable of eliminating fat and treating fatty liver obesity

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C05 Deemed withdrawal (patent law before 1993)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20121003